Correction: Immunoinformatics-driven multi-epitope vaccine design targeting PSMA, STEAP1, and B7H3 for prostate cancer

Correction on: Runtunuwu SVBE, Tallei TE, Kim HJ, Park MN, Celik I, Kirilmaz B, Turalaki GLA, Fatimawali F, Tendean LEN, Kaseke MM, Makawaehe DR, Rambi EV and Kim B (2026) Immunoinformatics-driven multi-epitope vaccine design targeting PSMA, STEAP1, and B7H3 for prostate cancer. Front. Med. 13:1716345. doi: 10.3389/fmed.2026.1716345 Adding/removing text In the published article, there was an inconsistency between the antigenicity score reported in the text and the value shown in Table 8. The text reported an antigenicity score of 0.9093, whereas Table 8 reports the correct antigenicity score of 0.8364.A correction has been made to the section 3.6 Vaccine construct formulation and evaluation:Original text: "The antigenicity of the final vaccine construct was evaluated, yielding a score of 0.9093, confirming its intrinsic antigenic potential."Corrected text: "The antigenicity of the final vaccine construct was evaluated, yielding a score of 0.8364, confirming its intrinsic antigenic potential."The original version of this article has been updated.In the published article, there was a typographical duplication in the molecular dynamics methods sentence ("was performed using was prepared using").A correction has been made to the section 2.9 Molecular dynamics simulation:Original text: "The simulation was performed using was prepared using the CHARMM-GUI online server due to its compatibility with efficient protein-water simulations and standard force fields, and the simulations were run using AMBER ff14SB force fields in GROMACS version 2023 (GROMACS Development Team, Stockholm, Sweden) (67)."Corrected text: "The system was prepared using the CHARMM-GUI online server due to its compatibility with efficient protein-water simulations and standard force fields, and simulations were performed using the AMBER ff14SB force fields in GROMACS version 2023 (GROMACS Development Team, Stockholm, Sweden) (67)."The original version of this article has been updated.In the published article, a sentence in the Discussion was duplicated consecutively.. The original version of this article has been updated.In the published article, there was a typographical error in the Discussion section.. A correction has been made to the Discussion section: Original text: "…rather than vaccine-induced tolerancee (119).Corrected text: "…rather than vaccine-induced tolerance (119)."The original version of this article has been updated.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-05-08
DOI
https://doi.org/10.3389/fmed.2026.1824612
Primary Topic
vaccines and immunoinformatics approaches
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Immunoinformatics-driven multi-epitope vaccine design targeting PSMA, STEAP1, and B7H3 for prostate cancer

Bonglee Kim, Elne Vieke Rambi, Grace L. A. Turalaki, Trina Ekawati Tallei et al.
Frontiers in Medicine
vaccines and immunoinformatics approaches
article

Correction: Immunoinformatics-driven multi-epitope vaccine design targeting PSMA, STEAP1, and B7H3 for prostate cancer

Bonglee Kim, Elne Vieke Rambi, Grace L. A. Turalaki, Trina Ekawati Tallei, Fatimawali Fatimawali, İ. Çelik, Stefanus Vicky Bernhard Elisa Runtunuwu, Dionisius Rafael Makawaehe, Lydia Estelina Naomi Tendean, Burak Kirilmaz, Martha Marie Kaseke, Moon Nyeo Park, Hyo Jeong Kim
article en

Abstract

Correction on: Runtunuwu SVBE, Tallei TE, Kim HJ, Park MN, Celik I, Kirilmaz B, Turalaki GLA, Fatimawali F, Tendean LEN, Kaseke MM, Makawaehe DR, Rambi EV and Kim B (2026) Immunoinformatics-driven multi-epitope vaccine design targeting PSMA, STEAP1, and B7H3 for prostate cancer. Front. Med. 13:1716345. doi: 10.3389/fmed.2026.1716345 Adding/removing text In the published article, there was an inconsistency between the antigenicity score reported in the text and the value shown in Table 8. The text reported an antigenicity score of 0.9093, whereas Table 8 reports the correct antigenicity score of 0.8364.A correction has been made to the section 3.6 Vaccine construct formulation and evaluation:Original text: "The antigenicity of the final vaccine construct was evaluated, yielding a score of 0.9093, confirming its intrinsic antigenic potential."Corrected text: "The antigenicity of the final vaccine construct was evaluated, yielding a score of 0.8364, confirming its intrinsic antigenic potential."The original version of this article has been updated.In the published article, there was a typographical duplication in the molecular dynamics methods sentence ("was performed using was prepared using").A correction has been made to the section 2.9 Molecular dynamics simulation:Original text: "The simulation was performed using was prepared using the CHARMM-GUI online server due to its compatibility with efficient protein-water simulations and standard force fields, and the simulations were run using AMBER ff14SB force fields in GROMACS version 2023 (GROMACS Development Team, Stockholm, Sweden) (67)."Corrected text: "The system was prepared using the CHARMM-GUI online server due to its compatibility with efficient protein-water simulations and standard force fields, and simulations were performed using the AMBER ff14SB force fields in GROMACS version 2023 (GROMACS Development Team, Stockholm, Sweden) (67)."The original version of this article has been updated.In the published article, a sentence in the Discussion was duplicated consecutively.. The original version of this article has been updated.In the published article, there was a typographical error in the Discussion section.. A correction has been made to the Discussion section: Original text: "…rather than vaccine-induced tolerancee (119).Corrected text: "…rather than vaccine-induced tolerance (119)."The original version of this article has been updated.

Frontiers in MedicineVol. 13
Kyung Hee University (KR), Cancer Research Center (US), Politeknik Kesehatan Kemenkes Semarang (ID), Sam Ratulangi University (ID), Erciyes University (TR)
Good health and well-being
Openalex Percentile: Top 8%
vaccines and immunoinformatics approaches
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.